삼성바이오, 국민연금 반대에도 ‘잡음없이’ 주총 원안 승인<br /><br />Shareholders voted in favor of Samsung BioLogics' key proposals despite the National Pension Service's opposition, citing the firm's alleged accounting fraud. <br />At the company's annual shareholders' meeting, shareholders approved the financial statement and the appointment of inside and outside executives. <br />Samsung BioLogics' president vowed to continue winning more contracts for biopharmaceutical research and production.
